GY

Guangzhou Yue Min Investment

Description

Guangzhou Yue Min Investment is an investment firm

Investor Profile

Guangzhou Yue Min Investment has backed more than 1 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 1 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series B rounds (top funding stages).
  • Majority of deals are located in United States.
  • Strong thematic focus on Biotechnology, Health Care, Oncology.

Stage Focus

  • Series B (100%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Oncology
  • Pharmaceutical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Guangzhou Yue Min Investment frequently co-invest with?

OrbiMed
North America, New York, United States, New York
Co-Investments: 1
K2VC
Asia, Beijing, China, Beijing
Co-Investments: 1
JC
Asia, Hong Kong Island, Hong Kong, Hong Kong
Co-Investments: 1
South China Venture Capital
Asia, Guangdong, China, Shenzhen
Co-Investments: 1
CMB International Capital Corporation
Asia, Hong Kong Island, Hong Kong, Central
Co-Investments: 1
Pan-Lin Capital
Asia, Shanghai, China, Shanghai
Co-Investments: 1

What are some of recent deals done by Guangzhou Yue Min Investment?

Apollomics

Foster City, California, United States

Apollomics is a biopharmaceutical company discovering and developing mono- and combination- oncology therapies to harness the immune system.

BiotechnologyHealth CareOncologyPharmaceutical
Series BJan 8, 2019
Amount Raised: $100,000,000